These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27819247)

  • 1. Generic oncology drugs: are they all safe?
    Yang YT; Nagai S; Chen BK; Qureshi ZP; Lebby AA; Kessler S; Georgantopoulos P; Raisch DW; Sartor O; Hermanson T; Kane RC; Hrushesky WJ; Riente JJ; Norris LB; Bobolts LR; Armitage JO; Bennett CL
    Lancet Oncol; 2016 Nov; 17(11):e493-e501. PubMed ID: 27819247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between the quality aspects of various generic and branded docetaxel formulations.
    Yiding C; Zhongyi H
    Curr Med Res Opin; 2021 Aug; 37(8):1421-1433. PubMed ID: 33998944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence Evaluations of Generic Dry Powder Inhaler Drug Products: Similarities and Differences Between Japan, USA, and the European Union.
    Kuribayashi R; Yamaguchi T; Sako H; Takishita T; Takagi K
    Clin Pharmacokinet; 2017 Mar; 56(3):225-233. PubMed ID: 27461251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definition and Classification of Generic Drugs Across the World.
    Alfonso-Cristancho R; Andia T; Barbosa T; Watanabe JH
    Appl Health Econ Health Policy; 2015 Aug; 13 Suppl 1(Suppl 1):S5-11. PubMed ID: 26091708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.
    Kesselheim AS; Polinski JM; Fulchino LA; Isaman DL; Gagne JJ
    Drugs; 2015 Apr; 75(6):633-50. PubMed ID: 25822610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory approval pathways for anticancer drugs in Japan, the EU and the US.
    Nagai S; Ozawa K
    Int J Hematol; 2016 Jul; 104(1):73-84. PubMed ID: 27084259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory Considerations for Approval of Generic Inhalation Drug Products in the US, EU, Brazil, China, and India.
    Lee SL; Saluja B; García-Arieta A; Santos GM; Li Y; Lu S; Hou S; Rebello J; Vaidya A; Gogtay J; Purandare S; Lyapustina S
    AAPS J; 2015 Sep; 17(5):1285-304. PubMed ID: 26002510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Generic Drug Reviews for Marketing Authorization between Japan and Canada.
    Kuribayashi R; Appleton S
    Drugs R D; 2017 Sep; 17(3):371-379. PubMed ID: 28577294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic medications for hepatitis C.
    Jensen DM; Sebhatu P; Reau NS
    Liver Int; 2016 Jul; 36(7):925-8. PubMed ID: 27306302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interchangeability, Safety and Efficacy of Modified-Release Drug Formulations in the USA: The Case of Opioid and Other Nervous System Drugs.
    Seoane-Vazquez E; Rodriguez-Monguio R; Hansen R
    Clin Drug Investig; 2016 Apr; 36(4):281-92. PubMed ID: 26818406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [GENERIC DRUGS: IS BIOEQUIVALENCE SUFFICIENT TO ENSURE QUALITY, EFFICACY AND SAFETY?].
    Carrillo Norte JA; Postigo Mota S
    Rev Enferm; 2015 May; 38(5):42-5. PubMed ID: 26540896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M; Theodore WH
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Generic drugs: we must cut pharmaceutical spending but undertaking drug quality].
    Carrillo Norte JA; Postigo Mota S
    Rev Enferm; 2012 Feb; 35(2):10-9. PubMed ID: 22670381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer.
    Tagawa N; Sugiyama E; Tajima M; Sasaki Y; Nakamura S; Okuyama H; Shimizu H; Sato VH; Sasaki T; Sato H
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):841-849. PubMed ID: 28864856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence of generic drugs.
    Andrade C
    J Clin Psychiatry; 2015 Sep; 76(9):e1130-1. PubMed ID: 26455677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence: the regulatory career of a pharmaceutical concept.
    Carpenter D; Tobbell DA
    Bull Hist Med; 2011; 85(1):93-131. PubMed ID: 21551918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affordability and availability of off-patent drugs in the United States-the case for importing from abroad: observational study.
    Gupta R; Bollyky TJ; Cohen M; Ross JS; Kesselheim AS
    BMJ; 2018 Mar; 360():k831. PubMed ID: 29555641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On safety margin for drug interchangeability.
    Zheng J; Chow SC; Song F
    J Biopharm Stat; 2017; 27(2):293-307. PubMed ID: 27911675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generics Substitution, Bioequivalence Standards, and International Oversight: Complex Issues Facing the FDA.
    Bate R; Mathur A; Lever HM; Thakur D; Graedon J; Cooperman T; Mason P; Fox ER
    Trends Pharmacol Sci; 2016 Mar; 37(3):184-191. PubMed ID: 26687297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
    Chua GN; Hassali MA; Shafie AA; Awaisu A
    Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.